impossibility-preemption

4 cases — ← All topics

Case Title Lower Court Docketed Status Flags Tags Question Presented
22-472 Association des Éleveurs de Cananards et D'oies du Quebéc, et al. v. Rob Bonta, Attorney General of California Ninth Circuit 2022-11-18 Denied Amici (5)Relisted (2) dormant-commerce-clause federal-preemption impossibility-preemption ingredient-preemption ingredient-requirements poultry-products poultry-products-inspection-act state-regulation usda-approval usda-regulation Whether a State may avoid express ingredient preemption under the Poultry Products Inspection Act by banning the sale of poultry products based on the…
20-1069 Janssen Pharmaceuticals, Inc., et al. v. A. Y., et al. Pennsylvania 2021-02-05 Denied Amici (4) civil-liability drug-labeling fda-regulation federal-preemption impossibility-preemption off-label-use preemption state-tort-law Whether federal law preempts state-law claims that a manufacturer failed to provide adequate warnings relating to the off-label use of their products,…
18-1140 Avco Corporation v. Jill Sikkelee, Individually and as Personal Representative of the Estate of David Sikkelee, Deceased, et al. Third Circuit 2019-03-04 Denied CVSGAmici (8)Response RequestedResponse WaivedRelisted (3) aircraft-design aviation-safety design-defect federal-aviation-act federal-preemption field-preemption impossibility-preemption preemption product-liability state-law Whether the Federal Aviation Act preempts state-law design-defect claims
18-803 Wendy B. Dolin v. GlaxoSmithKline, LLC, fka SmithKline Beecham Corporation Seventh Circuit 2018-12-21 Denied Relisted (2) clinical-trials drug-labeling drug-manufacturer fda-regulations impossibility-preemption labeling-changes preemption truthful-risks unilateral-labeling-changes unilateral-warning wyeth-v-levine Does federal law prevent a drug manufacturer from enhancing its label to reflect truthful risks revealed in its clinical trials when the relevant FDA …